|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1275 Pennsylvania Avenue, NW |
Address2 | Suite 700 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Woonsocket |
State | RI |
Zip Code | 02895 |
Country | USA |
|
5. Senate ID# 302778-12
|
||||||||
|
6. House ID# 394420000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Shannon Penberthy |
Date | 4/22/2019 6:28:12 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Issues related to medication adherence, drug price transparency, and prescription drug abuse.
H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019
H.R. 1034/S. 640, The Phair Pricing Act of 2019
H.R. 1035, The Prescription Drug Price Transparency Act of 2019
H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brooks |
|
|
|
Shannon |
Penberthy |
|
|
|
Tegan |
Gelfand |
|
|
|
Amy |
Rosenbaum |
|
|
|
Rosalyn |
Kumar |
|
Deputy Chief of Staff, Rep. Wasserman Schultz; Deputy Chief of Staff, Rep. Pocan; Tax Counsel, Sen. Stabenow; Legislative Director, Rep. Polis;
Legislative Assistant, Rep. Wasserman Schultz; Director of Operations, Rep. Eddie Bernice Johnson |
|
Sarah |
Schmidt |
|
Health Policy Advisor, Senator Rob Portman; Legislative Assistant, Rep. Michael Burgess
|
|
Joy |
McGlaun |
|
Deputy Staff Director, Senate Special Committee on Aging; Senior Policy Advisor, Legislative Assistant, Sen. Russell D. Feingold; Legislative Assistant, Rep. Vic Snyder; Legislative Assistant, Rep. Jim Turner |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act.
S. 80, The Jobs and Premium Protection Act
S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tegan |
Gelfand |
|
|
|
Amy |
Rosenbaum |
|
|
|
Glen |
Chambers |
|
Chief of Staff - Office of the Vice Chair, Senate Republican Conference; Chief of Staff - Office of Sen. Roy Blunt; Chief of Staff - Office of Sen. Sam Brownback
|
|
Shannon |
Penberthy |
|
|
|
Sarah |
Schmidt |
|
Health Policy Advisor, Senator Rob Portman; Legislative Assistant, Rep. Michael Burgess |
|
Melissa |
Schulman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs.
Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees.
Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020.
S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019
S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019
H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019
H.R. 1034/S. 640, The Phair Pricing Act of 2019
H.R. 1035, The Prescription Drug Price Transparency Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brooks |
|
|
|
Shannon |
Penberthy |
|
|
|
Amy |
Rosenbaum |
|
|
|
Tegan |
Gelfand |
|
|
|
Melissa |
Schulman |
|
|
|
Rosalyn |
Kumar |
|
Deputy Chief of Staff, Rep. Wasserman Schultz; Deputy Chief of Staff, Rep. Pocan; Tax Counsel, Sen. Stabenow; Legislative Director, Rep. Polis;
Legislative Assistant, Rep. Wasserman Schultz; Director of Operations, Rep. Eddie Bernice Johnson |
|
Sarah |
Schmidt |
|
Health Policy Advisor, Senator Rob Portman; Legislative Assistant, Rep. Michael Burgess |
|
Joy |
McGlaun |
|
Deputy Staff Director, Senate Special Committee on Aging; Senior Policy Advisor, Legislative Assistant, Sen. Russell D. Feingold; Legislative Assistant, Rep. Vic Snyder; Legislative Assistant, Rep. Jim Turner |
|
Glen |
Chambers |
|
Chief of Staff - Office of the Vice Chair, Senate Republican Conference; Chief of Staff - Office of Sen. Roy Blunt; Chief of Staff - Office of Sen. Sam Brownback
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to implementation and changes to the Affordable Care Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brooks |
|
|
|
Shannon |
Penberthy |
|
|
|
Amy |
Rosenbaum |
|
|
|
Tegan |
Gelfand |
|
|
|
Rosalyn |
Kumar |
|
Deputy Chief of Staff, Rep. Wasserman Schultz; Deputy Chief of Staff, Rep. Pocan; Tax Counsel, Sen. Stabenow; Legislative Director, Rep. Polis;
Legislative Assistant, Rep. Wasserman Schultz; Director of Operations, Rep. Eddie Bernice Johnson |
|
Sarah |
Schmidt |
|
Health Policy Advisor, Senator Rob Portman; Legislative Assistant, Rep. Michael Burgess |
|
Joy |
McGlaun |
|
Deputy Staff Director, Senate Special Committee on Aging; Senior Policy Advisor, Legislative Assistant, Sen. Russell D. Feingold; Legislative Assistant, Rep. Vic Snyder; Legislative Assistant, Rep. Jim Turner |
|
Glen |
Chambers |
|
Chief of Staff - Office of the Vice Chair, Senate Republican Conference; Chief of Staff - Office of Sen. Roy Blunt; Chief of Staff - Office of Sen. Sam Brownback
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS.
H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019
S. 64, The Preserve Access to Affordable Generics Act of 2019
S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019
H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019
S. 659, The Biologic Patent Transparency Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Penberthy |
|
|
|
Melissa |
Schulman |
|
|
|
Elizabeth |
Brooks |
|
|
|
Amy |
Rosenbaum |
|
|
|
Tegan |
Gelfand |
|
|
|
Rosalyn |
Kumar |
|
Deputy Chief of Staff, Rep. Wasserman Schultz; Deputy Chief of Staff, Rep. Pocan; Tax Counsel, Sen. Stabenow; Legislative Director, Rep. Polis;
Legislative Assistant, Rep. Wasserman Schultz; Director of Operations, Rep. Eddie Bernice Johnson |
|
Sarah |
Schmidt |
|
Health Policy Advisor, Senator Rob Portman; Legislative Assistant, Rep. Michael Burgess |
|
Joy |
McGlaun |
|
Deputy Staff Director, Senate Special Committee on Aging; Senior Policy Advisor, Legislative Assistant, Sen. Russell D. Feingold; Legislative Assistant, Rep. Vic Snyder; Legislative Assistant, Rep. Jim Turner |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Issues related to employer, small group and individual insurance markets, including surprise billing.
S. 657, The Drug Price Transparency Act of 2019
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Penberthy |
|
|
|
Amy |
Rosenbaum |
|
|
|
Tegan |
Gelfand |
|
|
|
Elizabeth |
Brooks |
|
|
|
Melissa |
Schulman |
|
|
|
Rosalyn |
Kumar |
|
Deputy Chief of Staff, Rep. Wasserman Schultz; Deputy Chief of Staff, Rep. Pocan; Tax Counsel, Sen. Stabenow; Legislative Director, Rep. Polis;
Legislative Assistant, Rep. Wasserman Schultz; Director of Operations, Rep. Eddie Bernice Johnson |
|
Sarah |
Schmidt |
|
Health Policy Advisor, Senator Rob Portman; Legislative Assistant, Rep. Michael Burgess |
|
Joy |
McGlaun |
|
Deputy Staff Director, Senate Special Committee on Aging; Senior Policy Advisor, Legislative Assistant, Sen. Russell D. Feingold; Legislative Assistant, Rep. Vic Snyder; Legislative Assistant, Rep. Jim Turner |
|
Glen |
Chambers |
|
Chief of Staff - Office of the Vice Chair, Senate Republican Conference; Chief of Staff - Office of Sen. Roy Blunt; Chief of Staff - Office of Sen. Sam Brownback
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |